跳至主要内容
临床试验/IRCT20180122038471N1
IRCT20180122038471N1招募中3 期

Evaluation of the effect of pentoxifylline 400 mg on anemia control and decreasing the dose of erythropoietin in chronic hemodialysis patients

rology Research Centre, Guilan University of Medical Sciences0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • GFR less than 15
  • Have been under hemodialysis for at least 3 months
  • Performing regular hemodialysis 3 times a week
  • Having an iron saturation of more than 30% and ferritin more than 500
  • Dialysis adequacy criteria: Kt/V greater than 1/2
  • Have an arteriovenous fistula or a pacifier for hemodialysis
  • Hemoglobin less than 11 in at least 2 consecutive tests within a month

排除标准

  • History of bleeding in a recent month
  • History of infection leading to hospitalization in a recent month
  • Use of theophylline and androgens
  • Intolerance to drug use in oral form
  • Patient dissatisfaction
  • The patient has undergone blood transfusion or B12 administration for any reason during the last 3 months.
  • The presence of any underlying illness that justifies anemia, including thyroid and parathyroid dysfunction, hemoglobinopathy and malnutrition, and ...
  • Hemorrhagic retinopathy
  • The presence of coronary artery disease in the last 3 months

研究者

发起方
rology Research Centre, Guilan University of Medical Sciences

相似试验